What is the current Price Target for the Vallon Pharmaceuticals Inc stock?

The average Vallon Pharmaceuticals Inc target price is $104.04. This is 7,384.89% higher than the current stock price. The highest price target is 12,741.73%, the lowest is 2,370.50%. 3 Analysts have issued a price target Vallon Pharmaceuticals Inc 2026 .

How high will the Vallon Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Vallon Pharmaceuticals Inc stock will rise. The performance of stocks, including the Vallon Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Vallon Pharmaceuticals Inc stock today?

The performance of Vallon Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Vallon Pharmaceuticals Inc stock fall?

The decline in Vallon Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Vallon Pharmaceuticals Inc Forecast, price target & analysts

$1.39

4.14% yesterday

Nasdaq, Aug 21, 10:00 pm CET

ISIN

US92023M1018

Symbol

GRI

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Vallon Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Vallon Pharmaceuticals Inc Classifications & Recommendation:

Buy

83%

Hold

17%

Vallon Pharmaceuticals Inc Price Target

Target Price	$104.04
Price	$1.39
Potential	7,384.89% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Vallon Pharmaceuticals Inc 2026 . The average Vallon Pharmaceuticals Inc target price is $104.04. This is 7,384.89% register free of charge higher than the current stock price. The highest price target is $178.50 12,741.73% register free of charge , the lowest is $34.34 2,370.50% register free of charge .
	A rating was issued by 6 analysts: 5 Analysts recommend Vallon Pharmaceuticals Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Vallon Pharmaceuticals Inc stock has an average upside potential 2026 of 7,384.89% register free of charge . Most analysts recommend the Vallon Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-54.56	-4.09
	99.13%	92.50%
P/E		negative

3 Analysts have issued a Vallon Pharmaceuticals Inc forecast for earnings per share. The average Vallon Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-54.56	99.13%
2025	$-4.09 92.50% Unlock
2026	$-2.19 46.45% Unlock
2027	$-0.44 79.91% Unlock
2028	$-0.35 20.45% Unlock

Current	-0.07	148.53%
2025	-0.35 417.75% Unlock
2026	-0.66 88.57% Unlock
2027	-3.26 393.94% Unlock
2028	-4.10 25.77% Unlock

Vallon Pharmaceuticals Inc...

Current Vallon Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 11 2025
Ascendiant Capital	Locked ➜ Locked	Locked	May 27 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 14 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 09 2024
Ascendiant Capital	Locked ➜ Locked	Locked	Dec 05 2024
Ascendiant Capital	Locked ➜ Locked	Locked	Oct 08 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 11 2025
Locked Ascendiant Capital: Locked ➜ Locked	May 27 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 14 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 09 2024
Locked Ascendiant Capital: Locked ➜ Locked	Dec 05 2024
Locked Ascendiant Capital: Locked ➜ Locked	Oct 08 2024

Discover more stocks with a high price target

Alibaba Group Holding Ltd 30.78%

Rheinmetall 28.98%

Coinbase Global, Inc. 27.38%

BioNTech SE - ADR 26.61%

Microsoft 26.43%

PayPal 24.57%

Deutsche Telekom 22.62%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now